FIELD: organic chemistry, medicine.
SUBSTANCE: invention describes a compound of the formula (I):
wherein R1 is chosen from the following group: (C1-C6)-alkyl, (C2-C6)-alkylidene, (C2-C6)-alkenyl, (C2-C6)-alkynyl, -O-(C1-C6)-alkyl, -O-(C2-C6)-alkenyl; m = 1; C3-C4 mean -CH2-CH or -CH=C, or C4 represents -CH and C3 absents; R2 and R3 represent hydrogen atom (H); or R2, R3, m and C3-C4 form compound of the formula:
; each among R4 and R5 is chosen independently from group comprising H, halogen atom, hydroxy-group, (C1-C6)-alkyl, -O-(C1-C6)-alkyl; L1 and L2 represent biradicals chosen from group comprising -(CR6)=C(R7), -C(R6)=N and -N=C(R6)-, -S-; Y is chosen from group consisting of oxygen atom (O) and two hydrogen atoms; X is chosen from group comprising -C(R6)(R7)-C(R6)(R7)-, -C(R6)=C(R7)-, -O-C(R6)(R7)-, -C(R6)(R7-O-, -S-C(R6)(R7)-, -C(R6)(R7)-S- and -S-. Invention describes compositions comprising compounds of the formula (I), method for enhancing activity of muscarinic receptors of subtype M1, method for treatment of diseases associated with muscarinic receptors.
EFFECT: valuable medicinal properties of compounds and composition.
14 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF BENZIMIDAZOLIDINONE AS AGENTS FOR MUSCARINIC RECEPTORS | 2002 |
|
RU2288919C2 |
MUSCARINIC AGONISTS | 2001 |
|
RU2269523C2 |
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, USING PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION OF CATHEPSIN S ACTIVITY | 2001 |
|
RU2317988C2 |
METHOD FOR TREATMENT OF ALLERGY BY USING SUBSTITUTED PYRAZOLES | 2001 |
|
RU2290179C2 |
TRICYCLIC OXAZOLIDINONE ANTIBIOTIC COMPOUNDS | 2009 |
|
RU2530884C2 |
OXAZOLIDINE ANTIBIOTICS | 2009 |
|
RU2516701C2 |
HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND THEIR USING | 2001 |
|
RU2289581C2 |
HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USE THEREOF | 2016 |
|
RU2743360C2 |
INHIBITORS OF AKT ACTIVITY | 2010 |
|
RU2579513C2 |
5-AMINOCYCLYLMETHYLOXAZOLIDIN-2-ONE DERIVATIVES | 2008 |
|
RU2492169C2 |
Authors
Dates
2007-01-27—Published
2002-12-23—Filed